Nadia Rosenthal
Inventor
Stats
- 0 US patents issued
- 5 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 0 US Patents Issued
- 5 US Applications Filed
- 11 Total Citation Count
- Aug 16, 2013 Most Recent Filing
- Nov 29, 2005 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| UNIVERSITY OF ROME | 1
| 2005
|
| EUROPEAN MOLECULAR BIOLOGY LABORATORY | 1
1 | 2005
2013 |
| FUNDACION CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III | 1
| 2006
|
| FUNDACIÓN CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III (CNIC) | 1
| 2013
|
Inventor Addresses
| Address | Duration |
|---|---|
| Heidelberg, DE | Feb 05, 09 - Aug 06, 15 |
| Monterotondo, IT | Jun 14, 07 - Jun 14, 07 |
| Rome, IT | Feb 19, 09 - Feb 19, 09 |
| St Kilda, AU | Sep 25, 14 - Sep 25, 14 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A01K: | ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS | 1 |
| A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 1 |
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 5 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2015/0218,539 | 2015 | METHODS OF USING THE CALCINEURIN A VARIANT CNAB1 FOR THE TREATMENT OF CARDIAC HYPERTROPHY | 0 |
| 2014/0286,906 | 2014 | USE OF IGF-1 IN THE MODULATION OF TREG CELL ACTIVITY AND THE TREATMENT AND PREVENTION OF AUTOIMMUNE DISORDERS OR DISEASES | 1 |
| 2009/0047,259 | 2009 | Methods of Using the Calcineurin A Variant CnA-beta 1 | 0 |
| 2009/0038,022 | 2009 | IGF-1 Novel peptides | 0 |
| 2007/0135,340 | 2007 | IGF-1 novel peptides | 7 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.